The upregulation of Mmut and the consequent accumulation of methylmalonic acid in high-risk TEAD3 + melanoma cells suggest that targeting these metabolic pathways could disrupt tumor progression mechanisms, particularly in aggressive subtypes such as acral melanoma. This evidence concerns the gene MMUT and acral lentiginous melanoma.